Platelet-rich plasma (PRP) in dental and oral surgery: from the wound healing to bone regeneration

Immunity & Ageing

Giuseppina Campisi¹  Bianca Polizzi¹  Maria E Licata¹  Antonino Albanese¹ 

[1] Department of Surgical, Oncological and Oral Sciences (Di.Chir. On.S.), Università degli studi di Palermo, Via del Vespro, 129, 90127 Palermo, Italy

关键词: BRONJ;    Implant surgery;    Periodontal surgery;    Tooth extraction;    Oral surgery;    Dental surgery;    Bone regeneration;    Wound healing;    PRP;   

Others  :  814986
DOI  :  10.1186/1742-4933-10-23

 received in 2013-01-14, accepted in 2013-06-02,  发布年份 2013

【 摘 要 】

Platelet-rich plasma (PRP) is a new approach to tissue regeneration and it is becoming a valuable adjunct to promote healing in many procedures in dental and oral surgery, especially in aging patients. PRP derives from the centrifugation of the patient's own blood and it contains growth factors that influence wound healing, thereby playing an important role in tissue repairing mechanisms. The use of PRP in surgical practice could have beneficial outcomes, reducing bleeding and enhancing soft tissue healing and bone regeneration. Studies conducted on humans have yielded promising results regarding the application of PRP to many dental and oral surgical procedures (i.e. tooth extractions, periodontal surgery, implant surgery). The use of PRP has also been proposed in the management of bisphosphonate-related osteonecrosis of the jaw (BRONJ) with the aim of enhancing wound healing and bone maturation. The aims of this narrative review are: i) to describe the different uses of PRP in dental surgery (tooth extractions and periodontal surgery) and oral surgery (soft tissues and bone tissue surgery, implant surgery and BRONJ surgery); and ii) to discuss its efficacy, efficiency and risk/benefit ratio. This review suggests that the use of PRP in the alveolar socket after tooth extractions is certainly capable of improving soft tissue healing and positively influencing bone regeneration but the latter effect seems to decrease a few days after the extraction. PRP has produced better results in periodontal therapy in association with other materials than when it is used alone. Promising results have also been obtained in implant surgery, when PRP was used in isolation as a coating material. The combination of necrotic bone curettage and PRP application seem to be encouraging for the treatment of refractory BRONJ, as it has proven successful outcomes with minimal invasivity. Since PRP is free from potential risks for patients, not difficult to obtain and use, it can be employed as a valid adjunct in many procedures in oral and dental surgery. However, further RCTs are required to support this evidence.

【 授权许可】

   
2013 Albanese et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Carlson NE, Roach RB: Platelet-rich plasma: clinical applications in dentistry. J Am Dent Assoc 2002, 133:1383-1386.
• [2]Kao RT, Murakami S, Beirne OR: The use of biologic mediators and tissue engineering in dentistry. Periodontol 2000 2009, 50:127-153.
• [3]Nikolidakis D, Jansen JA: The biology of platelet-rich plasma and its application in oral surgery: literature review. Tissue Engineering: Part B 2008, 14:249-258.
• [4]El-Sharkawy H, Kantarci A, Deady J, Hasturk H, Liu H, Alshahat M, Van Dyke TE: Platelet rich plasma: growth factors and pro- and anti-inflammatory properties. J Periodontol 2007, 78:661-669.
• [5]Anitua E, Andia I, Ardanza B, Nurden P, Nurden AT: Autologous platelets as source of proteins for healing and tissue regeneration. Thromb Haemost 2004, 91:4-15.
• [6]Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR: Platelet rich plasma. Oral Surg Oral Med Oral Pathol 1998, 85:638-646.
• [7]Fennis JP, Stoelinga PJ, Jansen JA: Mandibular reconstruction: a histological and histomorphometric study on the use of autogenous scaffolds, particulate corticocancellous bone grafts and platelet rich plasma in goats. Int J Oral Maxillofac Surg 2004, 33:48-55.
• [8]Del Corso M, Vervelle A, Simonpieri A, Jimbo R, Inchingolo F, Sammartino G, Dohan Ehrenfest DM: Current knowledge and perspectives for the use of platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) in oral and maxillofacial surgery part 1: Periodontal and dentoalveolar surgery. Curr Pharm Biotechnol. 2012, 13:207-230.
• [9]Plachokova AS, Nikolidakis D, Mulder J, Jansen JA, Creugers NH: Effect of platelet-rich plasma on bone regeneration in dentistry: a systematic review. Clin Oral Implants Res 2008, 19:539-545.
• [10]Bae JH, Kim YK, Myung SK: Effects of platelet-rich plasma on sinus bone graft: meta-analysis. J Periodontol 2011, 82:660-667.
• [11]Holly D, Mracna J: The use of platelet rich plasma with guided tissue regeneration indefects caused by periodontal diseases. Bratisl Lek Listy 2009, 110:669-671.
• [12]Choi BH, Im CJ, Huh JY, Suh JJ, Lee SH: Effect of platelet-rich plasma on bone regeneration in autogenous bone graft. Int J Oral Maxillofac Surg 2004, 33:56-59.
• [13]Arora NS, Ramanayake T, Ren YF, Romanos GE: Platelet-rich plasma in sinus augmentation procedures: a systematic literature review: Part II. Implant Dent 2010, 19:145-157.
• [14]Nikolidakis D, Wolke JG, Jansen JA: Effect of platelet-rich plasma on the early bone formation around Ca-P-coated and non-coated oral implants in cortical bone. Clin Oral Implants Res 2008, 19:207-213.
• [15]Cetiner S, Sucak GT, Kahraman SA, Aki SZ, Kocakahyaoglu B, Gultekin SE, Cetiner M, Haznedar R: Osteonecrosis of the jaw in patients with multiple myeloma treated with zoledronic acid. J Bone Miner Metab 2009, 27:435-443.
• [16]Curi MM, Cossolin GS, Koga DH, Araújo SR, Feher O, dos Santos MO, Zardetto C: Treatment of avascular osteonecrosis of the jaw in cancer patients with a history of bisphosphonate therapy by combining bone resection and autologous platelet-rich plasma: report of 3 cases. J Oral Maxillofac Surg 2007, 65:349-355.
• [17]Lee CY, David T, Nishime M: Use of platelet- rich plasma in the management of oral bisphosphonate-associated osteonecrosis of the jaw: a report of 2 cases. J Oral Implantol 2007, 33:371-382.
• [18]Bocanegra-Perez S, Vicente-Barrero M, Knezevic M, Castellano-Navarro JM, Rodrıguez-Bocanegra E, Rodrıguez-Millares J, Perez-Plasencia D, Ramos- Macıas A: Use of platelet-rich plasma in the treatment of bisphosphonate-related osteonecrosis of the jaw. Int J Oral Maxillofac Surg 2012, 41:1410-1415.
• [19]Adornato MC, Morcos I, Rozanski J: The treatment of bisphosphonate-associated osteonecrosis of the jaws with bone resection and autologous platelet-derived growth factors. J Am Dent Assoc 2007, 138:971-977.
• [20]Mozzati M, Gallesio G, Arata V, Pol R, Scoletta M: Platelet-rich therapies in the treatment of intravenous bisphosphonate-related osteonecrosis of the jaw: a report of 32 cases. Oral Oncolin press
• [21]Coviello V, Peluso F, Dehkhargani SZ, Verdugo F, Raffaelli L, Manicone PF, D' Addona A: Platelet-rich plasma improves wound healing in multiple myeloma bisphosphonate-associated osteonecrosis of the jaw patients. J Biol Regul Homeost Agents. 2012, 26:151-155.
• [22]Huttner EA, Machado DC, de Oliveira RB, Antunes AG, Hebling E: Effects of human aging on periodontal tissues. Spec Care Dentist 2009, 29:149-155.
• [23]McCreary C, Ni Riordáin R: Systemic diseases and the elderly. Dent Update 2010, 37:604-607.
• [24]Dickersin K, Scherer R, Lefebvre C: Identifying relevant studies for systematic reviews. BMJ 1994, 309:1286-91.
• [25]Marx RE: Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg 2004, 62:489-496.
• [26]Marx RE: Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant Dent 2001, 10:225-228.
• [27]Marx RE: Platelet-rich plasma: a source of multiple autologous growth factors for bone grafts. In Tissue Engineering: Applications in Maxillofacial Surgery and Periodontics. Edited by Lynch SE, Genco RJ, Marx RE. Chicago: Quintessence; 1999:71-82.
• [28]Yang D, Cheng J, Jing Z, Jin D: Platelet-derived growth factor (PDGF)-AA: a self-imposed cytokine in the proliferation of human fetal osteoblasts. Cytokine 2000, 12:1271-1274.
• [29]Cochran DL, Wozney JM: Biological mediators for periodontal regeneration. Periodontology 2000, 19:40-58.
• [30]Rose LF, Rosenberg E: Bone grafts and growth and differentiation factors for regenerative therapy: a review. Pract Proced Aesthet Dent 2001, 13:725-734.
• [31]Bouloux GF, Steed MB, Perciaccante VJ: Complications of third molar surgery. Oral Maxillofac Surg Clin North Am 2007, 19:117-128.
• [32]Bacci C, Maglione M, Favero L, Perini A, Di Lenarda R, Berengo M, Zanon E: Management of dental extraction in patients undergoing anticoagulant treatment. Results from a large, multicentre, prospective, case-control study. Thromb Haemost. 2010, 104:972-975.
• [33]Lins RD, Dantas EM, Lucena KC, Catão MH, Granville-Garcia AF, Carvalho Neto LG: Biostimulation effects of low-power laser in the repair process. An Bras Dermatol. 2010, 85:849-855.
• [34]Alissa R, Esposito M, Horner K, Oliver R: The influence of platelet-rich plasma on the healing of extraction sockets: an explorative randomised clinical trial. Eur J Oral Implantol 2010, 3:121-134.
• [35]Ogundipe OK, Ugboko VI, Owotade FJ: Can autologous platelet-rich plasma gel enhance healing after surgical extraction of mandibular third molars? J Oral Maxillofac Surg 2011, 69:2305-2310.
• [36]Rutkowski JL, Johnson DA, Radio NM, Fennell JW: Platelet rich plasma to facilitate wound healing following tooth extraction. J Oral Implantol 2010, 36:11-23.
• [37]Célio-Mariano R, Morais de Melo W, Carneiro-Avelino C: Comparative radiographic evaluation of alveolar bone healing associated with autologous platelet-rich plasma after impacted mandibular third molar surgery. J Oral Maxillofac Surg 2012, 70:19-24.
• [38]Arenaz-Búa J, Luaces-Rey R, Sironvalle-Soliva S, Otero-Rico A, Charro-Huerga E, Patiño-Seijas B, García-Rozado A, Ferreras-Granados J, Vázquez-Mahía I, Lorenzo-Franco F, Martín-Sastre R, López-Cedrún JL: A comparative study of platelet-rich plasma, hydroxyapatite, demineralized bone matrix and autologous bone to promote bone regeneration after mandibular impacted third molar extraction. Med Oral Patol Oral Cir Bucal 2010, 15:483-489.
• [39]Gürbüzer B, Pikdöken L, Urhan M, Süer BT, Narin Y: Scintigraphic evaluation of early osteoblastic activity in extraction sockets treated with platelet-rich plasma. J Oral Maxillofac Surg 2008, 66:2454-2460.
• [40]Kawase T, Okuda K, Wolff LF, Yoshie H: Platelet-rich plasma-derived fibrin clot formation stimulates collagen synthesis in periodontal ligament and osteoblastic cells in vitro. J Periodontol 2003, 74:858-864.
• [41]Kanno T, Takahashi T, Tsujisawa T, Ariyoshi W, Nishihara T: Platelet-rich plasma enhances human osteoblast-like cell proliferation and differentiation. J Oral Maxillofac Surg 2005, 63:362-369.
• [42]Martínez-Zapata MJ, Martí-Carvajal A, Solà I, Bolibar I, Angel Expósito J, Rodriguez L, García J: Efficacy and safety of the use of autologous plasma rich in platelets for tissue regeneration: a systematic review. Transfusion 2009, 49:44-56.
• [43]Pradeep AR, Pai S, Garg G, Devi P, Shetty SK: A randomized clinical trial of autologous platelet-rich plasma in the treatment of mandibular degree II furcation defects. J Clin Periodontol 2009, 36:581-588.
• [44]Del Fabbro M, Bortolin M, Taschieri S, Weinstein R: Is platelet concentrate advantageous for the surgical treatment of periodontal diseases? A systematic review and meta-analysis. J Periodontol 2011, 82:1100-1111.
• [45]Menezes LM, Rao J: Long-term clinical evaluation of platelet-rich plasma in the treatment of human periodontal intraosseous defects: a comparative clinical trial. Quintessence Int 2012, 43:571-582.
• [46]Saini N, Sikri P, Gupta H: Evaluation of the relative efficacy of autologous platelet-rich plasma in combination with β-tricalcium phosphate alloplast versus an alloplast alone in the treatment of human periodontal infrabony defects: a clinical and radiological study. Indian J Dent Res 2011, 22:107-115.
• [47]Bharadwaj T, Kaushick BT, Jayakumar ND, Padmalatha O, Varghese S: Treatment of human periodontal infrabony defects with hydroxyapatite + β tricalcium phosphate bone graft alone and in combination with platelet rich plasma: a randomized clinical trial. Indian J Dent Res 2011, 22:505-510.
• [48]Ozdemir B, Okte E: Treatment of intrabony defects with beta-tricalciumphosphate alone and in combination with platelet-rich plasma. J Biomed Mater Res B Appl Biomater 2012, 100:976-983.
• [49]Harnack L, Boedeker RH, Kurtulus I, Boehm S, Gonzales J, Meyle J: Use of platelet-rich plasma in periodontal surgery—a prospective randomised double blind clinical trial. Clin Oral Invest 2009, 13:179-187.
• [50]Rodrigues SV, Acharya AB, Thakur SL: An evaluation of platelet-rich plasma without thrombin activation with or without anorganic bone mineral in the treatment of human periodontal intrabony defects. Platelets 2011, 22:353-360.
• [51]Döri F, Nikolidakis D, Húszár T, Arweiler NB, Gera I, Sculean A: Effect of platelet-rich plasma on the healing of intrabony defects treated with an enamel matrix protein derivative and a natural bone mineral. J Clin Periodontol 2008, 35:44-50.
• [52]Döri F, Kovács V, Arweiler NB, Huszár T, Gera I, Nikolidakis D, Sculean A: Effect of platelet-rich plasma on the healing of intrabony defects treated with an anorganic bovine bone mineral: a pilot study. J Periodontol 2009, 80:1599-1605.
• [53]Piemontese M, Aspriello SD, Rubini C, Ferrante L, Procaccini M: Treatment of periodontal intrabony defects with demineralized freeze-dried bone allograft in combination with platelet-rich plasma: a comparative clinical trial. J Periodontol 2008, 79:802-810.
• [54]Keceli HG, Sengun D, Berberoğlu A, Karabulut E: Use of platelet gel with connective tissue grafts for root coverage: a randomized-controlled trial. J Clin Periodontol 2008, 35:255-262.
• [55]Garcia RV, Gabrielli MA, Hochuli-Vieira E, Spolidorio LC, Filho JG, Neto FA, de Cardoso LA, Shibli JA: Effect of platelet-rich plasma on peri-implant bone repair: A histologic study in dogs. J Oral Implantol 2010, 36:281-290.
• [56]Daif ET: Effect of autologous platelet-rich plasma on bone regeneration in mandibular fractures. Dent Traumatolin press
• [57]Wojtowicz A, Chaberek S, Urbanowska E, Ostrowski K: Comparison of efficiency of platelet rich plasma, hematopoieic stem cells and bone marrow in augmentation of mandibular bone defects. NY State Dent J 2007, 73:41-45.
• [58]Esposito M, Grusovin MG, Rees J, Karasoulos D, Felice P, Alissa R, Worthington HV, Coulthard P: Interventions for replacing missing teeth: augmentation procedures of the maxillary sinus. Cochrane Database Syst Rev 2010., 17CD008397
• [59]Khairy NM, Shendy EE, Askar NA, El-Rouby DH: Effect of platelet rich plasma on bone regeneration in maxillary sinus augmentation (randomized clinical trial). Int J Oral Maxillofac Surgin press
• [60]Poeschl PW, Ziya-Ghazvini F, Schicho K, Buchta C, Moser D, Seemann R, Ewers R, Schopper C: Application of platelet-rich plasma for enhanced bone regeneration in grafted sinus. J Oral Maxillofac Surg 2012, 70:657-664.
• [61]Cabbar F, Güler N, Kürkcü M, Işeri U, Sençift K: The effect of bovine bone graft with or without platelet-rich plasma on maxillary sinus floor augmentation. J Oral Maxillofac Surg 2011, 69:2537-2547.
• [62]Anitua EA: Enhancement of osseointegration by generating a dynamic implant surface. J Oral Implantol 2006, 32:72-76.
• [63]Gentile P, Bottini DJ, Spallone D, Curcio BC, Cervelli V: Application of platelet-rich plasma in maxillofacial surgery: clinical evaluation. J Craniofac Surg 2010, 21:900-904.
• [64]Anand U, Mehta DS: Evaluation of immediately loaded dental implants bioactivated with platelet-rich plasma placed in the mandibular posterior region: a clinico-radiographic study. J Indian Soc Periodontol 2012, 16:89-95.
• [65]Markiewicz MR, Margarone JE 3rd, Campbell JH, Aguirre A: Bisphosphonate-associated osteonecrosis of the jaws: a review of current knowledge. J Am Dent Assoc 2005, 136:1669-1674.
• [66]Yin G, Bai Y, Luo E: Angiogenic suppression of osteoclasts may play a role in developing bisphosphonate-related osteonecrosis of the jaw. Med Hypotheses 2011, 76:347-349.
• [67]Advisory Task Force on Bisphosphonate-Related Osteonecrosis of the Jaws: American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 2007, 65:369-376.
• [68]Montebugnoli L, Felicetti L, Gissi DB, Pizzigallo A, Pelliccioni GA, Marchetti C: Bisphosphonate-associated osteonecrosis can be controlled by nonsurgical management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007, 104:473-477.
• [69]Sanchez AR, Sheridan PJ, Kupp LI: Is platelet-rich plasma the perfect enhancement factor? A current review. Int J Oral Maxillofac Implants 2003, 18:93-103.
• [70]Dugrillon A, Eichler H, Kern S, Kliiter H: Autologous concentrated platelet-rich plasma (cPRP) for local application in bone regeneration. Int J Oral Maxillofac Surg 2002, 31:615-619.
• [71]Landesberg R, Roy M, Glickman RS: Quantification of growth factors levels using a simplified method of platelet rich plasma gel preparation. J Oral Maxillofac Surg 2000, 58:297-300.
• [72]Martínez-González JM, Sánchez JC, Lafuente JCG, Campo Trapero J, Esparza Gómez GC, Seoane Lestón JM: Do ambulatory-use Platelet-Rich Plasma (PRP) concentrates present risks? Medicina Oral 2002, 7:375-390.